Table 2.
Peptide LLO91-99 | CD4+ T cellsb | CD8+ T cells | CD4+c-IFNintracell | CD8+-IFNintracell |
---|---|---|---|---|
NVa | 25 ± 0.02 | 18 ± 0.01 | 0.03 ± 0.001 | 0.1 ± 0.001 |
ENDO/LLO | 33 ± 0.02 | 22 ± 0.03 | 0.02 ± 0.002 | 0.47 ± 0.002 |
ENDO-IFN/LLO | 29 ± 0.01 | 23 ± 0.01 | 0.05 ± 0.002 | 0.71 ± 0.004 |
BM-DM/LM | 35 ± 0.03 | 25 ± 0.02 | 0.04 ± 0.001 | 0.99 ± 0.007 |
BM-DM-IFN/LM | 30 ± 0.02 | 26 ± 0.03 | 0.02 ± 0.002 | 1.4 ± 0.02 |
Peptide LLO189-201 | ||||
NV | 28 ± 0.01 | 19 ± 0.02 | 0.19 ± 0.005 | 0.01 ± 0.0 |
ENDO/LLO | 31 ± 0.03 | 21 ± 0.03 | 0.40 ± 0.02 | 0.03 ± 0.001 |
ENDO-IFN/LLO | 29 ± 0.02 | 23 ± 0.03 | 0.56 ± 0.04 | 0.03 ± 0.002 |
BM-DM/LM | 34 ± 0.01 | 27 ± 0.02 | 0.68 ± 0.06 | 0.01 ± 0.001 |
BM-DM-IFN/LM | 32 ± 0.03 | 28 ± 0.03 | 0.78 ± 0.05 | 0.0 ± 0.0 |
CBA/J mice were vaccinated i.p or not (NV) with 30 µg of LLO loaded endosomes from resting BM-DM (ENDO/LLO), LLO loaded endosomes from IFN-γ activated BM-DM (ENDO-IFN/LLO), LM infected resting BM-DM (1 × 106 cells) or LM infected and IFN-γ activated BM-DM (1 × 106 cells) for 7 days (n = 5/vaccination type). Next, mice were inoculated with LM (5 × 103 bc/mice) for 3 days. Splenocytes were obtained from homogenized spleens after the vaccination protocol. Samples were performed in triplicates and results expressed the mean ± SD (p < 0.01).
Splenocytes from vaccinated mice were stimulated for 5 hours with LLO91-99 or LLO189-201 peptides in the presence of brefeldin A for intracellular cytokine staining. Stimulated cells were surface stained for CD4 FITC-labelled or CD8 FITC-labelled. Percentages of CD4+ or CD8+ T cells are expressed for each vaccination protocol. Samples were done in triplicates and results expressed the mean ± SD (p < 0.05).
LLO peptide stimulated splenocytes surface stained for CD4 or CD8 were fixed and permeabilized using a cytofix/cytoperm kit (BD. Biosciences). Cells were stained for IFN-γ using an anti-IFN-γ antibody PE-labelled. Samples were acquired using a FACSCanto flow cytometer. Data were gated to include exclusively CD4+ or CD8+ events, and the percentage of these cells expressing IFN-γ was determined. Samples were done in triplicates and results expressed the mean ± SD (p < 0.05).